BRIEF-Adimab says entered into agreement to transfer adimab platform to Lilly
July 18, 2017 at 09:15 AM EDT
* Adimab - entered into agreement with Eli Lilly to transfer Adimab platform to Lilly for discovery & optimization of antibody-based drugs in therapeutic areas Source text for Eikon: Further company coverage:
